XFXiucai Fang

Xiucai Fang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Xiucai Fang has a total of 317 co-authors. Here are the top co-authors by number of shared publications:

  • Guijun Fei

    Department of Gastroenterology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China

    9 shared publications
  • Mei-Yun Ke

    Department of Gastroenterology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China

    7 shared publications
  • Meiyun Ke

    Departement of Gastroenterology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

    6 shared publications
  • Xiaoqing Li

    Department of Gastroenterology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China

    6 shared publications
  • Ami D. Sperber

    Faculty of Health Sciences Ben‐Gurion University of the Negev Beer‐Sheva Israel

    5 shared publications
  • Xiaohong Sun

    Departement of Gastroenterology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

    5 shared publications

Latest Publications

  • Open Access

    Asian Neurogastroenterology and Motility Association and Asia-Pacific Association of Gastroenterology Chronic Constipation Consensus 2026

    by Tanisa Patcharatrakul, Kewin T. H. Siah, Ari Fahrial Syam, Atsushi Nakajima, Hidekazu Suzuki, Yeong Yeh Lee, Mariko Hojo, Pakkapon Rattanachaisit, Panyavee Pitisuttithum, Sabrina Quek, et al.

    Tanisa Patcharatrakul, Kewin T H Siah, Ari Fahrial Syam, Atsushi Nakajima, Hidekazu Suzuki, Yeong Yeh Lee, Mariko Hojo, Pakkapon Rattanachaisit, Panyavee Pitisuttithum, Sabrina Quek, Tao Bai, Yi Ping Ren, Akihito Nagahara, Andrew Ming- Liang Ong, Chien-Lin Chen, Ching-Liang Lu, Duc Trong Quach, Govind K Makharia, Justin C Y Wu, Kee Wook Jung, Kee Huat Chuah, Linda Zhong, M Masudur Rahman, Tae Hee Lee, Uday C Ghoshal, Xiaohua Hou, Xiucai Fang, Ying-Lian Xiao, and Sutep Gonlachanvit. J Neurogastroenterol Motil -0001;0:. https://doi.org/10.5056/jnm26076

  • Top Cited Papers
    Open Access

    Rome V global epidemiology and validation survey: prevalence of disorders of gut–brain interaction and comparison with the Rome IV global epidemiology study

    by Ami D Sperber, Johann P Hreinsson, Magnus Simrén, Douglas A Drossman, Viola Andresen, Serhat Bor, Dan L Dumitrascu, Xiucai Fang, Guijun Fei, Luis Bustos Fernandez, et al.

    Background: The recently published Rome V adult diagnostic criteria facilitated an updated epidemiological survey of disorders of gut–brain interaction (DGBI). Objective: We aimed to describe the global epidemiology of DGBI using the Rome V criteria and compare it with the Rome IV Rome Foundation Global Epidemiology Study. Methods: A population-based Internet survey of 28,771 adults was conducted in 15 countries using the Rome V diagnostic questionnaire. DGBI prevalence was determined and compared with the Rome IV data. Multivariable logistic regression models were used to examine associations of demographic factors to Rome V DGBI status in the global population and to assess potentially associated clinical factors. Results: The surveys yielded similar results. The prevalence of at least one DGBI using the Rome V criteria was 40.9%, compared with 40.5% for Rome IV. In both, the prevalence was higher among females and decreased with increasing age. In the Rome V sample (25 DGBI), the most prevalent oesophageal disorder was functional dysphagia at 4.1%, the most prevalent gastroduodenal disorder was functional dyspepsia at 8.1%, unclassified bowel disorder was the most prevalent bowel disorder (9.6%), followed by chronic constipation (8.9%) and IBS (8.5%) and proctalgia fugax was the most prevalent anorectal disorder (7.3%). The prevalence rates for two new DGBI were 5.1% for abdominal migraine and 1.4% for inability to belch syndrome. Conclusion: The Rome V global prevalence of DGBI is consistent with Rome IV. This bolsters confidence in the validity of prevalence rates for DGBI and reaffirms their high global burden.


  • Open Access

    Multinational prevalence and burden of paediatric disorders of gut–brain interaction: results of the Rome Foundation paediatric global study

    by Samuel Nurko, Tiffany Taft, Olafur S Palsson, Marc Benninga, Carlo DiLorenzo, Rachel Rosen, Miguel Saps, Johann P Hreinsson, Xiucai Fang, Mizu Jiang, et al.

    Background: Global prevalence estimates of paediatric disorders of gut–brain interaction (DGBI) are largely unknown and published studies are hindered by heterogeneous methodology. Objective: To determine the multinational prevalence and burden of paediatric DGBI as defined by Rome V. Design: Caregivers of 8000 children aged 0–17 years from China, Italy, Mexico and the USA completed an online Rome V survey assessing gastrointestinal symptoms, illness burden and comorbid health conditions. Prevalence was calculated by DGBI category, country, sex and age. Results: Paediatric DGBI were highly prevalent, affecting 28.0% (95% CI 27.0% to 29.0%) of children. Upper DGBI were present in 8.7% (95% CI 8.2% to 9.5%) and lower DGBI in 23.7% (95% CI 22.8% to 24.7%). The most common lower DGBI were defecation and anorectal disorders (20.2%) followed by abdominal pain disorders (4.4%) and discomfort disorders (1.8%). The most common upper DGBI were gastroduodenal disorders (6.6%), followed by functional feeding disorders (3.4%) and oesophageal disorders (0.6%). Significant geographic differences were observed with the highest prevalence in Mexico and the lowest in China. There was a female predominance in gastroduodenal and discomfort disorders. Overall prevalence declined with age, from approximately 41% in children aged 0–3 years to 22% in adolescents. DGBI were associated with significant anxiety, depression, functional disability and healthcare utilisation, as well as parental time spent in care and coordination particularly when upper and lower DGBI overlapped. Conclusions: This global Rome V study demonstrates the high multi-national prevalence, burden and heterogeneity of paediatric DGBI, supporting improved recognition, classification, research and clinical care


  • Open Access

    Translation, cross-cultural adaptation and validation of the Chinese version of irritable bowel syndrome severity scoring system

    by Qian Li, Jia-Hao Mo, Hui-Qi Chen, Meng-Xin Chen, Xiao-Jia Ni, Ze-Hui He, Bing-Xiong Ou, Xiu-Cai Fang, Xiao-Bo Yang

    Objective: Given that the Irritable Bowel Syndrome Severity Scoring System (IBS-SSS) is widely utilized in IBS-related clinical research but lacks an officially approved Chinese version (IBS-SSS-C), which has impeded its application in Chinese research contexts. This study aims to translate and cross-culturally adapt the IBS-SSS into a Chinese version, and validate its key properties, thereby developing a reliable and officially recognized tool for assessing IBS severity among the Chinese population. Methods: We obtained translation permission for the IBS-SSS from the Rome Foundation, and translated and cross-culturally adapted it into a Chinese version according to the official guideline. Validation was performed as clinical trials assessing responsiveness to change ( n = 95), test–retest reliability ( n = 35) and the floor-ceiling effects ( n = 95) of IBS-SSS-C. We assessed the IBS-SSS-C score’s responsiveness to change using adequate relief (AR) as an anchor. Results: Through forward and backward translation, and cross-cultural adaption, the IBS-SSS-C was developed and approved for use by the Rome Foundation. A significance difference in the absolute change of the IBS-SSS-C total score before and after treatment was found in the AR responder and non-responder groups ( p = 0.001). This trend also emerged for the items abdominal pain severity ( p = 0.032), abdominal pain frequency ( p = 0.001), and bowel habit satisfaction ( p = 0.036). There was good test–retest reliability ( r = 0.72) for the IBS-SSS-C total score, and a moderate to good correlation ( r = 0.41–0.81) for each of its items. No floor or ceiling effect was found in either IBS-SSS-C or any of its item. Conclusion: Our findings indicate that the IBS-SSS-C appears to be a reliable and appropriate instrument for IBS outcome assessment in the Chinese population; nevertheless, further validation in larger-scale, multi-center studies is required.


  • High-Frequency Gastric Electrical Stimulation Selectively Remodels Nitrergic Neurons in the Gastric Antrum of Healthy Beagles

    by Bo Huang, Mingyu Fu, Heer Yang, Xueqian Yang, Xin Wu, Yang Zhao, Guijun Fei, Jianing Li, Chunhua Hu, Pan Tang, et al.

  • Top Cited Papers
    Open Access

    Functional Dyspepsia and Its Subgroups: Prevalence and Impact in the Rome IV Global Epidemiology Study

    by J. Tack, O. S. Palsson, S. I. Bangdiwala, J. Schol, F. Carbone, K. Van Den Houte, B. Broeders, D. Drossman, D. L. Dumitrascu, X. Fang, et al.

    Background: Functional dyspepsia (FD) is one of the most common disorders of gut–brain interaction (DGBI). Varying reported population prevalences probably reflect different definitions and methodological approaches.Aim: To study the prevalence and impact of FD and its subgroups in an internet survey.Methods: A total of 54,127 respondents from 26 countries completed the survey including the Rome IV diagnostic questionnaire, Patient Health Questionnaire‐4 (PHQ‐4), PHQ‐12, PROMIS Global‐10, demographics, and medical history. Respondents reporting a history of relevant organic disease, or fulfilling criteria for self‐induced or cyclic vomiting, or cannabinoid hyperemesis were excluded.Results: Rome IV FD prevalence was 7.2% (range 2.2%–12.3%), significantly higher in women and decreased with age. The most prominent subtype was postprandial distress syndrome (PDS) (66.6%). Rome IV IBS was found in 26.1% of those fulfilling FD criteria. Functional heartburn and chronic nausea and vomiting criteria were fulfilled in, respectively, 9.0% and 7.0%. Fulfilling FD symptom criteria was significantly associated with increased prevalence of anxiety and depression and with lower quality of life and higher healthcare seeking behaviour.Conclusions: Rome IV FD is one of the most prevalent DGBI globally. Across countries, it is associated with female sex, younger age, psychological distress, reduced quality of life, and higher health care utilisation. PDS is the dominant subgroup. Overlapping other DGBI are present in a minority.


  • Open Access

    Glucose monitoring intelligent tracking system for remote glycemic assessment in diabetic dogs: a novel approach

    by Jiri Xi, Heer Yang, Qiang Zhang, Sicheng Yang, Fan Ping, Xiucai Fang

    Optimizing glucose control is one of the primary goals of diabetes management. This study assessed the feasibility and accuracy of a remote real-time continuous glucose monitoring system (RT-CGMS) integrated with intelligent tracking in diabetic dogs. Seven Beagle dogs were monitored using interstitial sensors across different configurations: adhesive only, adhesive with protective garments, and garments combined with an innovative glucose monitoring approach for remote transmission. Sensor wear time was slightly longer with garments (8.2 ± 6.7 vs. 5.8 ± 3.1 days; P > 0.05). Valid data acquisition was significantly higher in the remote-monitoring group [95 (84, 96)] compared to Group 1 [67 (47, 78)] and Group 2 [76 (64, 80), P < 0.001 for both]. A strong correlation was found between RT-CGMS and PBGM measurements (r = 0.904). Calibration improved accuracy at glucose levels ≥ 5.5 mmol/L, reducing MARD from 28.5 to 14.5% and increasing Bland-Altman agreement from 48 to 67%. However, MAD slightly increased in the < 5.5 mmol/L range (2.2 to 2.7 mmol/L). Frequent hyperglycemia, high variability, and glucose excursions were observed. In conclusion, RT-CGMS with intelligent tracking improved data continuity and accuracy in diabetic dogs. Future research should focus on improving the system’s sensitivity under hypoglycemic conditions and exploring its broader applications, including its role in enhancing in-hospital glucose management, utilizing big data to facilitate online diagnostics and offline follow-up care, providing guidance for daily glucose stabilization, enabling personalized veterinary services, and offering subscription-based health reports for pet owners.

  • Open Access

    Dynamic Relevance Between Reflux Events and Esophageal Motility in Patients With Proton Pump Inhibitor‐Refractory Gastroesophageal Reflux Disease

    by Si Hui Lin, Zhi Feng Wang, Hua Li, Xiao Hong Sun, Xiao Qing Li, Gui Jun Fei, Wei Guang Chen, Tao Guo, Mei Yun Ke, Xiu Cai Fang

    Objectives: The association between reflux events and esophageal motility abnormality is unclear. We aimed to determine the relevance between reflux events and esophageal motility in proton pump inhibitor (PPI)‐refractory gastroesophageal reflux disease (GERD).Methods: Patients with PPI‐refractory or PPI‐responsive GERD were enrolled. Ambulatory 24‐h esophageal pH–impedance–pressure monitoring was performed. Reflux symptoms, reflux events, and esophageal motility during acid reflux episodes were recorded and compared between the two groups.Results: Sixty patients with PPI‐refractory GERD and 18 with PPI‐responsive GERD were included, all of whom had pathological gastroesophageal reflux. There were no significant differences in the major acid reflux parameters (DeMeester score and proportion of patients with acid exposure time > 6%) between the two groups. However, the number of long acid reflux episodes and the time length of the longest reflux episodes were significantly higher in the PPI‐refractory GERD group than in the PPI‐responsive GERD group (both p < 0.05). Moreover, patients with PPI‐refractory GERD had higher rates of ineffective primary (62.0% vs. 36.0%, p < 0.001) and secondary peristalsis (83.5% vs. 57.0%, p = 0.001) during long acid exposure (LAE) than those with PPI‐responsive GERD. Patients with PPI‐refractory GERD having LAE had a significantly lower frequency of primary and secondary peristalsis per minute and required a longer time to initiate secondary peristalsis than those without during their longest acid reflux period in the upright position (all p < 0.001).Conclusion: Longer acid reflux episodes in patients with PPI‐refractory GERD might result from frequent ineffective primary esophageal peristalsis and delayed initiation of effective secondary peristalsis.


  • Open Access

    The COVID‐19 pandemic as a modifier of DGBI symptom severity: A systematic review and meta‐analysis

    by Dmitrii Kulin, Ayesha Shah, Thomas Fairlie, Reuben K. Wong, Xiucai Fang, Uday C. Ghoshal, Purna C. Kashyap, Agata Mulak, Yeong Yeh Lee, Nicholas J. Talley, et al.

    Background: This SRMA reviewed and assessed the changes in the severity of disorders of gut‐brain interaction (DGBI) symptoms during the COVID‐19 pandemic, and evaluated factors associated with symptom severity changes.Methods: Electronic databases were searched until February 2024, for articles reporting on changes in symptom severity in DGBI patients during the COVID‐19 pandemic. The proportion of DGBI patients who reported a change in their symptom severity were pooled using a random‐effects model, and subgroup analyses were conducted to assess the effect of socio‐cultural modifiers on symptom severity in DGBI.Key Results: Twelve studies including 3610 DGBI patients found that 31.4% (95% CI, 15.9–52.5) of DGBI patients experienced symptom deterioration, while 24.3% (95% CI, 10.2–47.5) experienced improvement. Countries with high gross domestic product (GDP) had a 43.5% (95% CI, 16.3–75.2) likelihood of symptom deterioration, compared to 9.2% (95% CI, 1.4–42.2) in lower GDP countries. Similarly, countries with low COVID fatality rates had a 60.1% (95% CI, 19.7–90.3) likelihood of symptom deterioration, compared to 18.3% (95% CI, 7.8–36.9) in higher fatality rate countries. Countries with lenient COVID policies had a 58.4% (95% CI, 14.1–92.3) likelihood of symptom deterioration, compared to 19% (95% CI, 8.2–38.1) in countries with stricter policies. Patients in high vaccine hesitancy countries had a 51.4% (95% CI, 19.5–82.2) likelihood of symptom deterioration, compared to 10.6% (95% CI, 2.7–33.4) in low vaccine hesitancy countries.Conclusions & Inferences: This meta‐analysis reveals that a significantly higher proportion of DGBI patients experienced deterioration of symptoms during the COVID‐19 pandemic. Various sociocultural, economic and environmental factors potentially modify the effects of the COVID‐19 pandemic on DGBI.


  • Open Access

    A multifaceted ecological approach to explore links between environmental factors and the epidemiology of disorders of gut–brain interaction

    by Thomas Fairlie, Ayesha Shah, Reuben K. Wong, Xiucai Fang, Uday C. Ghoshal, Purna C. Kashyap, Agata Mulak, Yeong Yeh Lee, Ami D. Sperber, Natasha Koloski, et al.

    Background: Disorders of gut–brain interaction (DGBI) are characterized by debilitating symptoms not explained by structural or biochemical abnormalities. While functional conditions present with complex, likely heterogeneous pathophysiology, we aimed to investigate if proxy measures of sociocultural and environmental factors are associated with the prevalence of various DGBI in populations across the world.Methods: We performed an ecological study utilizing peer‐reviewed published datasets reporting for 26 countries prevalence rates of DGBI (Rome Foundation Global Epidemiology Study, RFGES), with six independent variables: Helicobacter pylori prevalence and household size as proxy measures for orofecal infections, gross domestic product per capita (GDP), and median age as a proxy measures for socioeconomic development, density of fast food outlets (FFO) per 100,000 population as proxy measure for processed food exposure, and suicide mortality rate per 100,000 people, and world happiness scores were used as a proxy for psychological stress. The data were retrieved from publicly accessible datasets (United Nations, CIA World Factbook, World Bank, World Happiness Report, commercial/financial reports of a global FFO chain). We used linear regression to assess variables in univariate and multivariate analysis and report standardized β coefficients with 95% confidence intervals (CI).Key Results: The regression model revealed that the overall prevalence of DGBI was inversely associated with both GDP per capita (β = −0.57, 95% CI: −0.92, −0.22, p = 0.002) and happiness scores (β = −0.433 95% CI: 0.821, −0.065, p = 0.023), while being positively associated with H. pylori prevalence (β = 0.40, 95% CI: 0.008, 0.81, p = 0.046). The prevalence of functional constipation (FC) was also inversely associated with GDP per capita (β = −0.50, 95% CI: −0.86, −0.13, p = 0.01) and happiness scores (β = −0.497, 95% CI: −0.863, −0.132, p = 0.01), while being positively associated with H. pylori prevalence (β = 0.53, 95% CI: 0.16, 0.91, p = 0.007). The Multivariate model analysis revealed that combining the factors of H. pylori prevalence, suicide rate, household size and happiness scores showed statistically significant association with FC (p = 0.039). Household size (β = −0.43, 95% CI: −0.82, 0.038, p = 0.033) and suicide rates (β = 0.55, 95% CI: 0.19, 0.90, p = 0.004) were statistically significantly associated with functional diarrhea. Irritable bowel syndrome (IBS) was associated with GDP per capita (β = −0.40, 95% CI: −0.79, −0.014, p = 0.043) and happiness scores (β = −0.390, 95% CI: −0.778, −0.003, p = 0.049).Conclusions & Inferences: Utilizing publicly available data, the prevalence of DGBI across diverse countries is linked to various socio‐cultural and environmental factors. Collectively, the data suggests that the prevalence of DGBI is increased in less prosperous regions of the world.